ResearchISHLT Consensus Statement on Short Telomere Syndrome and Lung Transplantation: Authors' Perspective
ResearchCurrent challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025
ResearchArtificial Intelligence Among US Hematology Oncology Fellows: A Multicenter Survey of Education, Attitudes, and Clinical Use
ResearchComprehensive clinical characteristics and outcomes of stage IV EGFR-mutant NSCLC based on PD-L1 expression
ResearchClinical factors driving use of RET inhibitor pralsetinib and associated real-world outcomes in RET fusion–positive NSCLC: A retrospective chart review
ResearchRandomized multicenter phase II trial of radioimmunotherapy versus chemoimmunotherapy followed by surgery for c-stage IB-III NSCLC (RICHIS trial)
ResearchCaregiver-rated performance status as a missing clinical signal: Implications for anticancer treatment, NLR, and outcomes in hospitalized solid tumor patients
ResearchDon’t ask, don’t tell: Missing ECOGS and anticancer treatment, neutrophil-to-lymphocyte ratios, and outcomes in hospitalized patients with solid tumors
ResearchThe impact of preoperative imaging strategies in EGFR-mutant non-small cell lung cancer (NSCLC): A multi-center retrospective review
ResearchSecond-line therapy following osimertinib in metastatic EGFR-mutated non-small cell lung cancer at an academic medical center
ResearchImpact of performance status on outcomes for solid tumor patients receiving inpatient chemotherapy
ResearchUnderstanding workflow of inpatient chemotherapy and developing strategies to improve provider coordination and treatment delivery
ResearchRare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validation.
ResearchTERT c.3150 G > C (p.K1050N): a founder Ashkenazi Jewish variant associated with telomere biology disorders.
